(Q31092005)

English

One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

One-year results of bevacizumab intravitreal and posterior sub-Tenon injection of triamcinolone acetonide with reduced laser fluence photodynamic therapy for retinal angiomatous proliferation (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

based on heuristic

inferred from title

author name string

Yukari Shirakata

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Chieko Shiragami

2

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Ayana Yamashita

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Eri Nitta

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Atsushi Fujiwara

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Fumio Shiraga

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

publication date

19 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Japanese Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

56

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

599-607

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Retinal angiomatous proliferation in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Recurrence after surgical ablation for retinal angiomatous proliferation.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Photodynamic therapy with verteporfin for retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP).

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Influence of treatment parameters on selectivity of verteporfin therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Combination therapy of ranibizumab and photodynamic therapy for retinal angiomatous proliferation with serous pigment epithelial detachment in Korean patients: twelve-month results.

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Sequence of Early Vascular Events after Photodynamic Therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Rationale for combination therapies for choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1007%2FS10384-012-0183-Y

21 January 2018

Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic effects on choroidal neovascularization and physiological choroid

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological changes following photodynamic therapy in human eyes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22990616

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10384-012-0183-Y

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31092005&oldid=2195084406"